ArticleFrontiers in pharmacology2025

EUROCOVER-CLL: Reimbursement and accessibility of new treatments in relapsed/refractory chronic lymphocytic leukemia.

Magdalena Monica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.